Home/Filings/4/0001062993-24-015384
4//SEC Filing

Geist William 4

Accession 0001062993-24-015384

CIK 0000842023other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 5:29 PM ET

Size

22.7 KB

Accession

0001062993-24-015384

Insider Transaction Report

Form 4
Period: 2024-08-15
Geist William
PRESIDENT, PROTEIN SCIENCES
Transactions
  • Award

    Restricted Stock Units

    2024-08-15+7,8697,869 total
    Common Stock (7,869 underlying)
  • Award

    Performance Restricted Stock Units

    2024-08-15+15,73815,738 total
    Common Stock (15,738 underlying)
  • Award

    Stock Options (Right to Buy)

    2024-08-15+21,20421,204 total
    Exercise: $74.91Exp: 2034-08-15Common Stock (21,204 underlying)
Holdings
  • Restricted Stock Units

    Common Stock (3,320 underlying)
    3,320
  • Stock Options (Right to Buy)

    Exercise: $94.52Exp: 2029-08-15Common Stock (29,600 underlying)
    29,600
  • Performance Stock Options (Right to Buy)

    Exercise: $84.61Common Stock (24,424 underlying)
    24,424
  • Performance Stock Options (Right to Buy)

    Exercise: $94.52Common Stock (22,200 underlying)
    22,200
  • Common Stock

    4,439
  • Performance Restricted Stock Units

    Common Stock (9,074 underlying)
    9,074
  • Stock Options (Right to Buy)

    Exercise: $84.61Exp: 2030-08-15Common Stock (30,059 underlying)
    30,059
  • Stock Options (Right to Buy)

    Exercise: $100.39Exp: 2029-02-01Common Stock (15,912 underlying)
    15,912
  • Performance Restricted Stock Units

    Common Stock (7,140 underlying)
    7,140
  • Restricted Stock Units

    Common Stock (19,823 underlying)
    19,823
Footnotes (12)
  • [F1]3,320 restricted stock units previously reported in Table I have been moved to Table II and the Reporting Person's beneficial ownership has been updated accordingly.
  • [F10]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F11]2,623 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
  • [F12]Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F3]3,320 restricted stock units vest on 2/1/2025.
  • [F4]Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026.
  • [F5]Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F6]Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
  • [F7]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F8]Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
  • [F9]9,912 restricted stock units vest on 11/1/2024 and 9,911 restricted stock units vest on 11/1/2025.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001832210

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:29 PM ET
Size
22.7 KB